Alan De la Rosa

发表

Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case–Control Study

J. Eckel-Passow, T. Kellogg, A. Hashem, 2022, Obesity Surgery.

Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case–Control Study

J. Eckel-Passow, T. Kellogg, D. Hensrud, 2022, Obesity Surgery.

Association Between Food Intake and Gastrointestinal Symptoms in Patients With Obesity

Michael Camilleri, Gerardo Calderón, Daniel Gonzalez-Izundegui, 2022, Gastro hep advances.

Sex as an independent variable in the measurement of satiation: a retrospective cohort study

A. Acosta, D. Hensrud, S. Faubion, 2022, International Journal of Obesity.

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

Andres Acosta, Alejandro Campos, Lizeth Cifuentes, 2022, JAMA network open.

Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants.

Alison Mcrae, Andres Acosta, Alejandro Campos, 2022, Mayo Clinic proceedings.

Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study

Karen B. Grothe, R. Lennon, D. Hensrud, 2023, EClinicalMedicine.

A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center

Gerardo Calderón, Andres Acosta, Alejandro Campos, 2022, Obesity Pillars.

The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes

Diego Añazco, Alejandro Campos, Lizeth Cifuentes, 2024, Diabetes, obesity & metabolism.